An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)

Patent thickets

A large, dense, and overlapping set of patent rights, often around a single product or technology, which can make it difficult for competitors to enter the market.

Patent Group

A collection of two or more patents or patent applications that are owned by the same company and are legally related because they have been linked to prevent claiming the same invention twice.

Infringement action

A lawsuit brought by a patent holder against a party accused of making, using, or selling a patented invention without permission.

Generic drug

A drug that is identical or bioequivalent to a brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use, but is typically sold at a much lower price after the brand-name patent expires.

Biological product

A medical product made from living organisms or their products, such as vaccines, blood components, or gene therapies. Biosimilars are similar versions of existing biological products.

Obviousness-type double patenting

A legal principle preventing a patent owner from obtaining two separate patents for the same invention, or for an invention that is an obvious variation of an invention already patented by the same owner.